Effects of Rituximab on the Development of Viral and Fungal Infections in Renal Transplant Recipients
Figure 1
(a) Incidence of viral and fungal infections according to rituximab exposure in the entire cohort. (b) Incidence of viral and fungal infections, excluding patients treated for acute rejection. *represents all viral infections except for cytomegalovirus and BK.
